These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16273996)

  • 41. Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines.
    Koenigsknecht-Talboo J; Landreth GE
    J Neurosci; 2005 Sep; 25(36):8240-9. PubMed ID: 16148231
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-TLR2 antibody triggers oxidative phosphorylation in microglia and increases phagocytosis of β-amyloid.
    Rubio-Araiz A; Finucane OM; Keogh S; Lynch MA
    J Neuroinflammation; 2018 Aug; 15(1):247. PubMed ID: 30170611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease.
    Fukuchi K; Tahara K; Kim HD; Maxwell JA; Lewis TL; Accavitti-Loper MA; Kim H; Ponnazhagan S; Lalonde R
    Neurobiol Dis; 2006 Sep; 23(3):502-11. PubMed ID: 16766200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD47 does not mediate amyloid-β(1-42) protofibril-stimulated microglial cytokine release.
    Karki S; Nichols MR
    Biochem Biophys Res Commun; 2014 Nov; 454(1):239-44. PubMed ID: 25451248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
    Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
    Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Cattepoel S; Hanenberg M; Kulic L; Nitsch RM
    PLoS One; 2011 Apr; 6(4):e18296. PubMed ID: 21483675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.
    Schiltz JG; Salzer U; Mohajeri MH; Franke D; Heinrich J; Pavlovic J; Wollmer MA; Nitsch RM; Moelling K
    J Mol Med (Berl); 2004 Oct; 82(10):706-14. PubMed ID: 15241501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amelioration of amyloid load by anti-Abeta single-chain antibody in Alzheimer mouse model.
    Fukuchi K; Accavitti-Loper MA; Kim HD; Tahara K; Cao Y; Lewis TL; Caughey RC; Kim H; Lalonde R
    Biochem Biophys Res Commun; 2006 May; 344(1):79-86. PubMed ID: 16630540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.
    Yamanaka M; Ishikawa T; Griep A; Axt D; Kummer MP; Heneka MT
    J Neurosci; 2012 Nov; 32(48):17321-31. PubMed ID: 23197723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-Aβ Antibodies and Cerebral Amyloid Angiopathy Complications.
    Chantran Y; Capron J; Alamowitch S; Aucouturier P
    Front Immunol; 2019; 10():1534. PubMed ID: 31333665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TREM1 facilitates microglial phagocytosis of amyloid beta.
    Jiang T; Zhang YD; Gao Q; Zhou JS; Zhu XC; Lu H; Shi JQ; Tan L; Chen Q; Yu JT
    Acta Neuropathol; 2016 Nov; 132(5):667-683. PubMed ID: 27670763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A subcutaneous cellular implant for passive immunization against amyloid-β reduces brain amyloid and tau pathologies.
    Lathuilière A; Laversenne V; Astolfo A; Kopetzki E; Jacobsen H; Stampanoni M; Bohrmann B; Schneider BL; Aebischer P
    Brain; 2016 May; 139(Pt 5):1587-604. PubMed ID: 26956423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibodies bound to Aβ oligomers potentiate the neurotoxicity of Aβ by activating microglia.
    Morkuniene R; Zvirbliene A; Dalgediene I; Cizas P; Jankeviciute S; Baliutyte G; Jokubka R; Jankunec M; Valincius G; Borutaite V
    J Neurochem; 2013 Sep; 126(5):604-15. PubMed ID: 23745639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TGF-beta1 blockade of microglial chemotaxis toward Abeta aggregates involves SMAD signaling and down-regulation of CCL5.
    Huang WC; Yen FC; Shie FS; Pan CM; Shiao YJ; Yang CN; Huang FL; Sung YJ; Tsay HJ
    J Neuroinflammation; 2010 Apr; 7():28. PubMed ID: 20429874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complement component C1q modulates the phagocytosis of Abeta by microglia.
    Webster SD; Yang AJ; Margol L; Garzon-Rodriguez W; Glabe CG; Tenner AJ
    Exp Neurol; 2000 Jan; 161(1):127-38. PubMed ID: 10683279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
    PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.
    Bard F; Barbour R; Cannon C; Carretto R; Fox M; Games D; Guido T; Hoenow K; Hu K; Johnson-Wood K; Khan K; Kholodenko D; Lee C; Lee M; Motter R; Nguyen M; Reed A; Schenk D; Tang P; Vasquez N; Seubert P; Yednock T
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2023-8. PubMed ID: 12566568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque clearance by microglia in 5XFAD mice.
    Zhao P; Xu Y; Fan X; Li L; Li X; Arase H; Tong Q; Zhang N; An Z
    MAbs; 2022; 14(1):2107971. PubMed ID: 35921534
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice.
    Wilcock DM; Alamed J; Gottschall PE; Grimm J; Rosenthal A; Pons J; Ronan V; Symmonds K; Gordon MN; Morgan D
    J Neurosci; 2006 May; 26(20):5340-6. PubMed ID: 16707786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.